EMPIRE PETROLEUM CORP (EP)

US2920343033 - Common Stock

6.71  +1.11 (+19.82%)

After market: 6.68 -0.03 (-0.45%)

Fundamental Rating

1

Overall EP gets a fundamental rating of 1 out of 10. We evaluated EP against 205 industry peers in the Oil, Gas & Consumable Fuels industry. EP may be in some trouble as it scores bad on both profitability and health. EP is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

EP had negative earnings in the past year.
EP had a positive operating cash flow in the past year.
EP had negative earnings in 4 of the past 5 years.
In multiple years EP reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -13.86%, EP is doing worse than 91.67% of the companies in the same industry.
EP has a Return On Equity of -29.72%. This is amonst the worse of the industry: EP underperforms 87.25% of its industry peers.
Industry RankSector Rank
ROA -13.86%
ROE -29.72%
ROIC N/A
ROA(3y)-13.58%
ROA(5y)-50.16%
ROE(3y)-64.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 25.61%, EP is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
EP's Gross Margin has declined in the last couple of years.
EP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.56%
GM growth 5Y-21.52%

1

2. Health

2.1 Basic Checks

EP does not have a ROIC to compare to the WACC, probably because it is not profitable.
EP has more shares outstanding than it did 1 year ago.
EP has more shares outstanding than it did 5 years ago.
EP has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that EP is in the distress zone and has some risk of bankruptcy.
EP's Altman-Z score of 0.70 is on the low side compared to the rest of the industry. EP is outperformed by 64.71% of its industry peers.
EP has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.15, EP is doing good in the industry, outperforming 73.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACCN/A
WACC9.18%

2.3 Liquidity

EP has a Current Ratio of 0.43. This is a bad value and indicates that EP is not financially healthy enough and could expect problems in meeting its short term obligations.
EP's Current ratio of 0.43 is on the low side compared to the rest of the industry. EP is outperformed by 91.18% of its industry peers.
A Quick Ratio of 0.38 indicates that EP may have some problems paying its short term obligations.
The Quick ratio of EP (0.38) is worse than 89.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.38

3

3. Growth

3.1 Past

The earnings per share for EP have decreased strongly by -37.99% in the last year.
The Revenue has grown by 19.55% in the past year. This is quite good.
Measured over the past years, EP shows a very strong growth in Revenue. The Revenue has been growing by 143.78% on average per year.
EPS 1Y (TTM)-37.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.78%
Revenue 1Y (TTM)19.55%
Revenue growth 3Y73.09%
Revenue growth 5Y143.78%
Sales Q2Q%24.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EMPIRE PETROLEUM CORP

NYSEARCA:EP (12/20/2024, 8:07:17 PM)

After market: 6.68 -0.03 (-0.45%)

6.71

+1.11 (+19.82%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-11 2024-11-11
Earnings (Next)N/A N/A
Inst Owners11.2%
Inst Owner Change8.01%
Ins Owners52.59%
Ins Owner Change8.39%
Market Cap225.66M
AnalystsN/A
Price TargetN/A
Short Float %9.38%
Short Ratio45.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.04
P/FCF N/A
P/OCF 20.54
P/B 3.99
P/tB 3.99
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)0.33
OCFY4.87%
SpS1.33
BVpS1.68
TBVpS1.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.86%
ROE -29.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.61%
FCFM N/A
ROA(3y)-13.58%
ROA(5y)-50.16%
ROE(3y)-64.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.56%
GM growth 5Y-21.52%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 744.01%
Cap/Sales 129.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.38
Altman-Z 0.7
F-Score4
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)671.56%
Cap/Depr(5y)443.05%
Cap/Sales(3y)46.76%
Cap/Sales(5y)50.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.55%
Revenue growth 3Y73.09%
Revenue growth 5Y143.78%
Sales Q2Q%24.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-82.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-490.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.03%
OCF growth 3YN/A
OCF growth 5YN/A